Short answer
CVS Health (CVS) filed its Q3 2025 10-Q quarterly report on Oct 29, 2025 for the quarter ended Sep 30, 2025. Quarterly revenue was $102.9B (up 7.8% year over year) with net income of −$4.0B.
Q3 2025 key financials · XBRL
- Revenue
- $102.9B
- +7.8% YoY · +4.0% QoQ
- Net income
- −$4.0B
- −4669.0% YoY · −489.3% QoQ
- Operating margin
- -3.1%
- EPS (diluted)
- −$3.14
- −4585.7% YoY · −492.5% QoQ
Source: XBRL data from the CVS Health (CVS) Q3 2025 10-Q on SEC EDGAR. USD.
CVS Health Q3 2025 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Forward-looking statements caution under Reform Act, no updated guidance or outlook given
- No details on quarterly revenue, profitability, cash flow, or capital deployment available
Risk Factors
- No material changes to risk factors compared to 10-K, risks carried forward without update
- COVID-19 pandemic impact on operations and supply chain remains significant near-term operational risk
- Ongoing regulatory scrutiny on drug pricing and pharmacy operations could affect revenue and compliance costs
- High debt levels and refinancing risk amid volatile interest rates impact financial liquidity position
- Currency exposure minimal, primary risk from concentrated US healthcare market and competitive pressures
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CVS Health quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.